{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:41:25Z","timestamp":1791229285852,"version":"4.1.0"},"reference-count":71,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T00:00:00Z","timestamp":1361318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Nail involvement in psoriasis is common and mostly occurs with other lesions but can also occur alone. Besides psychosocial and aesthetic impairments, patients often complain about functional impairment. Nail psoriasis is a predictor for more severe psoriasis, decreased quality of life, and a higher risk for the development of psoriatic arthritis. Onychomycosis and other differential diagnoses should be excluded prior to treatment. This article presents an overview of different clinical appearances of nail psoriasis, the essential diagnostic assessment before treatment, important differential diagnoses, and published data on treatment options for nail psoriasis.<\/jats:p>","DOI":"10.1111\/ddg.12054","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T13:31:57Z","timestamp":1361367117000},"page":"203-220","source":"Crossref","is-referenced-by-count":12,"title":["Nail psoriasis \u2013 a treatment challenge"],"prefix":"10.1111","volume":"11","author":[{"given":"Marc A.","family":"Radtke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian C.","family":"Beikert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,20]]},"reference":[{"key":"e_1_2_17_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09831.x"},{"key":"e_1_2_17_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2011.02.007"},{"key":"e_1_2_17_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000119415"},{"key":"e_1_2_17_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.073"},{"key":"e_1_2_17_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246274"},{"key":"e_1_2_17_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-002-0143-0"},{"key":"e_1_2_17_8_2","first-page":"34","article-title":"Diagnosis and management of nail psoriasis","volume":"99","author":"Sanchez\u2010Regna M","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_2_17_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70145-5"},{"key":"e_1_2_17_10_2","doi-asserted-by":"publisher","DOI":"10.1586\/17469872.3.3.339"},{"key":"e_1_2_17_11_2","first-page":"586","article-title":"HLA antigens in psoriatic arthritis","volume":"13","author":"Gladman DD","year":"1986","journal-title":"J Rheumatol"},{"key":"e_1_2_17_12_2","first-page":"174","article-title":"Nail psoriasis","volume":"50","author":"Farber EM","year":"1992","journal-title":"Cutis"},{"key":"e_1_2_17_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.073"},{"key":"e_1_2_17_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/11318180-000000000-00000"},{"key":"e_1_2_17_15_2","first-page":"340","article-title":"Onychomycosis in psoriatic patients \u2013 rationalization of systemic treatment","volume":"53","author":"Shemer A","year":"2009","journal-title":"Mycoses"},{"key":"e_1_2_17_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2007.00107.x"},{"key":"e_1_2_17_17_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.72468"},{"key":"e_1_2_17_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05992.x"},{"key":"e_1_2_17_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05115.x"},{"key":"e_1_2_17_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22590"},{"key":"e_1_2_17_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/511051"},{"key":"e_1_2_17_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-007-0397-0"},{"key":"e_1_2_17_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200478"},{"key":"e_1_2_17_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000182250"},{"key":"e_1_2_17_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080952"},{"key":"e_1_2_17_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel214"},{"key":"e_1_2_17_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03363.x"},{"key":"e_1_2_17_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21736"},{"key":"e_1_2_17_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000316177"},{"key":"e_1_2_17_30_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)00910-1"},{"key":"e_1_2_17_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02389.x"},{"key":"e_1_2_17_32_2","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell SE","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_17_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03344.x"},{"key":"e_1_2_17_34_2","article-title":"For the NAPPA task force group: Conception, development and validation of NAPPA, a novel questionnaire for the assessment of patient\u2010reported outcomes in nail psoriasis","author":"Augustin M","year":"2013","journal-title":"Submitted"},{"key":"e_1_2_17_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000316169"},{"key":"e_1_2_17_36_2","first-page":"1","article-title":"Nail psoriasis as a severity indicator: results from the PsoReal study","volume":"2","author":"Radtke MA","year":"2011","journal-title":"Patient Related Outcomes Measures"},{"key":"e_1_2_17_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2008.12.003"},{"key":"e_1_2_17_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2007.00112.x"},{"key":"e_1_2_17_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02031.x"},{"key":"e_1_2_17_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1962.01590100033009"},{"key":"e_1_2_17_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1973.tb02956.x"},{"key":"e_1_2_17_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1974.tb06724.x"},{"key":"e_1_2_17_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1976.tb15536.x"},{"key":"e_1_2_17_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1962.01590100033009"},{"key":"e_1_2_17_45_2","volume-title":"Diseases of the Nail and Their Management","author":"Baran R","year":"1984"},{"key":"e_1_2_17_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00663.x"},{"key":"e_1_2_17_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01253.x"},{"key":"e_1_2_17_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639909056030"},{"key":"e_1_2_17_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550252948220"},{"key":"e_1_2_17_50_2","doi-asserted-by":"publisher","DOI":"10.5070\/D31T20Z9WW"},{"key":"e_1_2_17_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02462.x"},{"key":"e_1_2_17_52_2","first-page":"279","article-title":"Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis","volume":"88","author":"Tzung TY","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_17_53_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639409084558"},{"key":"e_1_2_17_54_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018281"},{"key":"e_1_2_17_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1974.01630110033006"},{"key":"e_1_2_17_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1998.tb02386.x"},{"key":"e_1_2_17_57_2","first-page":"355","article-title":"Tazarotene 0,1% gel in the treatment of fingernail psoriasis: a double\u2010blind, randomized, vehicle\u2010controlled study","volume":"68","author":"Scher RK","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_17_58_2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archderm.1980.01640330061013","article-title":"Response of psoriasis nails to oral photochemotherapy","volume":"116","author":"Marx JL","year":"1980","journal-title":"Arch Dermatol"},{"key":"e_1_2_17_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1987.tb05834.x"},{"key":"e_1_2_17_60_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630701264331"},{"key":"e_1_2_17_61_2","first-page":"248","article-title":"Successful treatment of psoriasis nails with low\u2010dose cyclosporine administration","volume":"17","author":"Syuto T","year":"2007","journal-title":"Eur J Dermatol"},{"key":"e_1_2_17_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-004-0114-8"},{"key":"e_1_2_17_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2012.07919.x"},{"key":"e_1_2_17_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03927.x"},{"key":"e_1_2_17_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.600"},{"key":"e_1_2_17_66_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.111856"},{"key":"e_1_2_17_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09791.x"},{"key":"e_1_2_17_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03211.x"},{"key":"e_1_2_17_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24403"},{"key":"e_1_2_17_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.07.042"},{"key":"e_1_2_17_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6"},{"key":"e_1_2_17_72_2","unstructured":"RichP.Improvement in nail psoriasis with ustekinumab a new anti\u2010IL\u201012\/23 P40 monoclonal antibody: results from a phase 3 trial (PHOENIX 1).2008EADV Abstract FP1007."}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fddg.12054","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.12054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:39:02Z","timestamp":1697420342000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.12054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1111\/ddg.12054"],"URL":"https:\/\/doi.org\/10.1111\/ddg.12054","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,20]]}}}